for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

Gilead's remdesivir shaved 5 days off COVID-19 recovery time, reduced risk of death in some

CHICAGO, Oct 8 (Reuters) - Final data from Gilead Sciences Inc’s antiviral drug remdesivir showed the treatment cut COVID-19 recovery time by five days compared with patients who got a placebo, one day faster than previously reported preliminary data showed, the company and researchers said on Thursday. (Reporting by Julie Steenhuysen Editing by Chris Reese)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up